MILLENNIUM MANAGEMENT LLC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1273087
NEW YORK, NY
Position in ARWR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,844,258
+$23,855,513 QoQ
Shares Held
329,337
+631.6% QoQ
Ownership
0.233%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#53
of 497 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Derivatives in ARWR
reported options exposure · as of Jun 30, 2026CallValue
$6,374,082
CallShares
78,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,595,633,334 across 322 Biotechnology names. ARWR ranks #40 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in ARWR
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,844,258 | 329,337 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $6,374,082 | 78,200 | Call | Sole | 2026-08-14 | |
| 2025-12-31 | $2,988,745 | 45,018 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,787,243 | 109,807 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,670,847 | 169,041 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,800,741 | 690,796 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $17,193,540 | 914,550 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $12,505,349 | 645,604 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,755,233 | 529,251 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $9,351,370 | 326,971 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $8,292,431 | 308,613 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $11,710,494 | 328,393 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $24,622,607 | 969,394 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $23,347,309 | 575,624 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,601,497 | 78,714 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,830,037 | 137,178 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,414,685 | 139,480 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,032,492 | 30,656 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,997,826 | 48,019 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,990,247 | 24,031 | Shares | Sole | 2021-08-16 | |
| 2021-06-30 | $828,200 | 10,000 | Call | Sole | 2021-08-16 | |
| 2021-06-30 | $1,656,400 | 20,000 | Put | Sole | 2021-08-16 | |
| 2021-03-31 | $1,997,190 | 30,119 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,457,585 | 32,029 | Shares | Sole | 2021-02-16 | |
| 2020-12-31 | $2,301,900 | 30,000 | Call | Sole | 2021-02-16 | |
| 2020-09-30 | $8,105,786 | 188,244 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,159,500 | 50,000 | Call | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||